Approximately half of patients with heart failure have a preserved ejection fraction and although nitrates are commonly prescribed for symptom relief in heart failure, the effects in patients with heart failure and a preserved ejection fraction have not been extensively studied. In the UK NICE guidance only recommends use of nitrates with hydralazine for stage III or IV heart failure where patients are still symptomatic despite optimal ACEI and beta blocker therapy